FrancophonIA/ELRC3.0 huggingface dataset:
English: Some people, depending on why they need Abseamed treatment, may later learn how to inject themselves under the skin: see Instructions on how to inject Abseamed yourself at the end of the leaflet.
Danish: Nogle personer, afhængig af hvorfor de behøver behandling med Abseamed, kan senere lære at indsprøjte sig selv under huden: se ”Instruktion i,
English: Your doctor will decide how Abseamed will be injected.
Danish: Din læge vil bestemme, hvordan Abseamed skal indsprøjtes.
English: Abseamed and other products that stimulate red cell production may increase the risk of developing blood clots in all patients.
Danish: Abseamed og andre præparater, der stimulerer dannelsen af røde blodlegemer, kan øge risikoen for at udvikle blodpropper hos alle patienter.
English: Abseamed is a sterile but unpreserved product and is for single use only.
Danish: Abseamed er et sterilt præparat uden konserveringsmiddel og er kun til engangsbrug.
English: Take special care with Abseamed:
Danish: Vær særligt forsigtig med Abseamed:
English: You may still be able to use Abseamed, but discuss it with your doctor first:
Danish: Det er muligt, at du stadig kan bruge Abseamed, men du skal først tale med lægen om det:
English: Abseamed is prescribed to stimulate your bone marrow to produce more red blood cells.
Danish: Abseamed ordineres for at stimulere din knoglemarv til at danne flere røde blodlegemer.
English: If you visit a hospital, clinic or family doctor, tell them you are having Abseamed treatment.
Danish: Hvis du tager på hospitalet, en klinik eller til en praktiserende læge, skal du fortælle dem, at du får behandling med Abseamed.
English: If you develop a serious rash or another of these skin symptoms, stop taking Abseamed and contact your doctor or seek medical attention immediately.
Danish: Hvis du udvikler et alvorligt udslæt eller får andre af disse hudsymptomer, skal du stoppe med at tage Abseamed og straks kontakte din læge eller søge lægehjælp
English: You may still be able to use Abseamed, but discuss it with your doctor first.
Danish: Det kan være, at det stadig er muligt at bruge Abseamed, men du skal først tale med lægen om det.
English: The use of Abseamed in patients scheduled for major elective orthopaedic surgery and not participating in an autologous blood predonation programme is contraindicated in patients with severe coronary, peripheral arterial, carotid or cerebral vascular disease, including patients with recent myocardial infarction or cerebral vascular accident.
Danish: Brug af Abseamed hos patienter, der er planlagt til større elektiv ortopædkirurgi, og som ikke deltager i en autolog prædonation af blod, er kontraindiceret, hvis patienten lider af en alvorlig koronar, perifer arteriel, karotid eller cerebrovaskulær lidelse, herunder for nyligt har fået konstateret myokardieinfarkt eller hjerneblødning.
English: • Always use Abseamed exactly as instructed by your doctor or nurse.
Danish: • Brug altid Abseamed nøjagtigt efter lægens eller sundhedspersonalet anvisning.
English: What you need to know before you use Abseamed
Danish: Det skal du vide, før du begynder at tage Abseamed
English: • You may be given iron supplements before and during Abseamed treatment to make it more effective.
Danish: • Du kan få jerntilskud før og under behandlingen med Abseamed for at gøre det mere effektivt.
English: Where intravenous access is not readily available (patients not yet undergoing dialysis and peritoneal dialysis patients) Abseamed may be administered as a subcutaneous injection.
Danish: Hvis intravenøs adgang ikke er umiddelbart tilgængelig (patienter, som endnu ikke er i dialyse, og peritonealdialysepatienter), kan Abseamed administreres som subkutan injektion.
English: Alternatively, Abseamed can be administered at an initial dose of 450 IU/kg subcutaneously once weekly.
Danish: Alternativt kan Abseamed gives med en initialdosis på 450 IE/kg subkutant én gang ugentligt.
English: Mildly anaemic patients (haematocrit of 33 to 39%) requiring predeposit of ≥ 4 units of blood should be treated with Abseamed 600 IU/kg intravenously, 2 times per week for 3 weeks prior to surgery.
Danish: Patienter med let anæmi (hæmatokrit på 33 til 39%), som forud skal deponere ≥ 4 enheder blod, skal behandles med Abseamed 600 IE/kg intravenøst 2 gange ugentligt i 3 uger før operationen.
English: Caution should be exercised with escalation of Abseamed doses in patients with chronic renal failure since high cumulative epoetin doses may be associated with an increased risk of mortality, serious cardiovascular and cerebrovascular events.
Danish: Der skal udvises forsigtighed, når Abseamed-dosis øges hos patienter med kronisk nyreinsufficiens, da høje kumulative epoetindoser kan være forbundet med en øget risiko for mortalitet samt alvorlige kardiovaskulære og cerebrovaskulære hændelser.
English: The recommended starting dose is Abseamed 450 IU/kg (maximum total dose is 40,000 IU) administered subcutaneously once every week, with not less than 5 days between doses.
Danish: Den anbefalede startdosis er Abseamed 450 IE/kg (maksimal samlet dosis er 40.000 IE) administreret subkutant én gang om ugen og med mindst 5 dage mellem hver dosis.
English: Abseamed is used to treat symptomatic anaemia caused by kidney disease:
Danish: Abseamed bruges til at behandle symptomatisk anæmi forårsaget af nyresygdom:
English: Other medicines and Abseamed
Danish: Brug af anden medicin sammen med Abseamed
English: The recommended dose is Abseamed 600 IU/kg, administered subcutaneously weekly for three weeks (days -21, -14 and -7) prior to surgery and on the day of surgery (day 0).
Danish: Den anbefalede Abseamed-dosis er 600 IE/kg subkutant ugentligt i 3 uger (på dag - 21, - 14 og - 7) forud for operationsdagen samt på selve operationsdagen (dag 0).
English: Abseamed should be administered by the intravenous route.
Danish: Abseamed skal administreres intravenøst.
English: Abseamed is used to treat anaemia in adults with a bone marrow disorder that causes a severe disruption in the creation of blood cells (myelodysplastic syndromes).
Danish: Abseamed anvendes til at behandle anæmi hos voksne med en knoglemarvssygdom, der medfører svære forstyrrelser i dannelsen af blodlegemer (myelodysplastiske syndromer).
English: Abseamed is indicated for non-iron deficient adults prior to major elective orthopaedic surgery, having a high perceived risk for transfusion complications to reduce exposure to allogeneic blood transfusions.
Danish: Abseamed er indiceret hos voksne uden jernmangel forud for større elektive ortopædkirurgiske operationer, der indebærer en risiko for transfusionskomplikationer, til at nedsætte brugen af allogene blodtransfusioner.
English: Only take one dose of Abseamed from each syringe.
Danish: Tag kun en dosis af Abseamed fra hver sprøjte.
English: Patients should be monitored closely to ensure that the lowest approved effective dose of Abseamed is used to provide adequate control of anaemia and of the symptoms of anaemia whilst maintaining a haemoglobin concentration below or at 12 g/dL (7.5 mmol/L).
Danish: Patienter skal monitoreres nøje for at sikre, at der anvendes den laveste godkendte effektive dosis Abseamed til at opnå tilstrækkelig kontrol med anæmi og af anæmisymptomerne under opretholdelse af en hæmoglobinkoncentration under eller på 12 g/dl (7,5 mmol/l).
English: Abseamed is indicated in adults receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre-existing anaemia at the start of chemotherapy) for the treatment of anaemia and reduction of transfusion requirements.
Danish: Abseamed er indiceret hos voksne, der er i behandling med kemoterapi for alvorlige tumorer, malignt lymfom eller myelomatose samt ved risiko ved transfusion pga. patientens almentilstand (f.eks. dennes kardiovaskulære status eller allerede eksisterende anæmi ved start af kemoterapi) til behandling af anæmi og til nedsættelse af transfusionsbehovet.
English: (subcutaneously) yourself.
Danish: (subkutant).
English: Abseamed is not approved in the management of anaemia associated with hepatitis C.
Danish: Abseamed er ikke godkendt til behandling af anæmi forbundet med hepatitis C.
English: Instructions on how to inject Abseamed yourself
Danish: Vejledninger i, hvordan du selv skal indsprøjte Abseamed
English: Abseamed is used in moderately anaemic adults about to have major orthopaedic surgery (for example hip or knee replacement operations), to reduce the potential need for blood transfusions.
Danish: Abseamed anvendes til voksne med moderat anæmi, som skal have foretaget en større ortopædkirurgisk operation (for eksempel udskiftning af hofte eller knæ), for at nedsætte det eventuelle behov for blodtransfusioner.
English: If the haemoglobin level reaches 15 g/dL (9.38 mmol/L), or higher, during the preoperative period, administration of Abseamed should be stopped and further dosages should not be administered.
Danish: Hvis hæmoglobinværdien når 15 g/dl (9,38 mmol/l) eller derover i løbet af den præoperative periode, skal indgiften af Abseamed stoppes og yderligere doser ikke administreres.
English: Abseamed is used to treat anaemia in adults receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma (bone marrow cancer) who may have a need for a blood transfusion.
Danish: Abseamed anvendes til at behandle anæmi hos voksne, som får kemoterapi for solide svulster, ondartet lymfom eller myelomatose (knoglemarvskræft), og som kan have et behov for en blodtransfusion.
English: While on Abseamed, some people need medicines to reduce the risk of blood clots.
Danish: Tal med lægen om det. Nogle personer har behov for medicin for at reducere risikoen for blodpropper, mens de tager Abseamed.
English: Abseamed should be administered in order to increase haemoglobin to not greater than 11 g/dL (6.8 mmol/L).
Danish: Abseamed bør administreres for at øge hæmoglobin til ikke over 11 g/dl (6,8 mmol/l).
English: Patients should be monitored closely to ensure that the lowest approved dose of Abseamed is used to provide adequate control of anaemia and of the symptoms of anaemia.
Danish: Patienterne skal monitoreres nøje for at sikre, at der anvendes den laveste godkendte Abseamed-dosis til at opnå tilstrækkelig kontrol med anæmi og symptomerne på anæmi.
English: In cases where there is a medical need to shorten the lead time before surgery to less than three weeks, Abseamed 300 IU/kg should be administered subcutaneously daily for 10 consecutive days prior to surgery, on the day of surgery and for four days immediately thereafter.
Danish: I tilfælde, hvor der er en klinisk årsag til at afkorte behandlingstiden før operationen til mindre end tre uger, skal Abseamed 300 IE/kg administreres subkutant dagligt i 10 dage før operationen, på selve operationsdagen samt i de 4 første dage umiddelbart efter operationen.
English: If you are a patient with chronic renal failure, and particularly if you do not respond properly to Abseamed, your doctor will check your dose of Abseamed because repeatedly increasing your dose of Abseamed if you are not responding to treatment may increase the risk of having a problem of the heart or the blood vessels and could increase risk of myocardial infarction, stroke and death.
Danish: Hvis du har kronisk nyreinsufficiens, og især hvis du ikke reagerer korrekt på Abseamed, vil din læge kontrollere din Abseamed-dosis, da du har større risiko for at få et problem med hjertet eller blodkarrene, hvis din Abseamed-dosis skal øges gentagne gange, fordi du ikke reagerer på behandlingen.
English: Only take one dose of Abseamed from each syringe discarding unwanted solution before injection.
Danish: Tag kun en dosis fra hver sprøjte, og fjern den overflødige mængde opløsning før injektion.
English: “Instructions on how to inject Abseamed yourself” can be found at the end of the package leaflet.
Danish: ”Instruktion i, hvordan du giver dig selv en indsprøjtning med Abseamed” kan ses sidst i indlægssedlen.
English: Do not use Abseamed:
Danish: Tag ikke Abseamed:
English: Abseamed should be administered as a subcutaneous injection.
Danish: Abseamed skal administreres subkutant.
English: Abseamed is presented as a clear, colourless solution for injection in a pre-filled syringe.
Danish: Abseamed er en klar, farveløs injektionsvæske, opløsning.
English: In patients with a poor haemoglobin response to Abseamed, alternative explanations for the poor response should be considered (see section 4.4 and 5.1).
Danish: Hos patienter med et dårligt hæmoglobinrespons på Abseamed skal alternative forklaringer på det dårlige respons (se pkt.
English: Abseamed is indicated for the treatment of symptomatic anaemia (haemoglobin concentration of ≤ 10 g/dL) in adults with low- or intermediate-1-risk primary myelodysplastic syndromes (MDS) who have low serum erythropoietin (< 200 mU/mL).
Danish: hos voksne med primære myelodysplastiske syndromer (MDS) med lav eller intermediær risiko 1, som har lavt serum-erythropoietin (< 200 mE/ml).
English: • Before use, leave the Abseamed syringe to stand until it reaches room temperature.
Danish: • Før brug skal kanylen med Abseamed nå stuetemperatur.
English: Caution should be exercised with escalation of Abseamed doses in patients with chronic renal failure.
Danish: Der skal udvises forsigtighed, når Abseamed-dosis øges hos patienter med kronisk nyreinsufficiens.
English: Inject the Abseamed solution as you have been shown by your doctor.
Danish: Indsprøjt Abseamed opløsningen efter lægens anvisning.
English: Abseamed is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF):
Danish: Abseamed er indiceret til behandling af symptomatisk anæmi i forbindelse med kronisk nyreinsufficiens (CRF)
English: How to use Abseamed
Danish: Sådan skal du tage Abseamed
English: • You may take Abseamed out of the refrigerator and keep it at room temperature (up to 25°C) for no longer than 3 days.
Danish: • Du må gerne tage Abseamed ud af køleskabet og opbevare det ved rumtemperatur (op til
English: Abseamed should be administered in order to increase haemoglobin to not greater than 12 g/dL (7.5 mmol/L).
Danish: Abseamed bør administreres for at øge hæmoglobin til ikke over 12 g/dl (7,5 mmol/l).
English: Abseamed contains less than 1 mmol sodium (23 mg) per dose that is to say essentially “sodium free”.
Danish: Abseamed indeholder mindre end 1 mmol (23 mg) natrium pr. dosis, det vil sige, den er i det væsentlige natriumfri.
English: Abseamed should be administered to patients with symptomatic anaemia (e.g. haemoglobin concentration ≤ 10 g/dL (6.2 mmol/L)).
Danish: Abseamed bør administreres til patienter med symptomatisk anæmi (f.eks. hæmoglobinkoncentration ≤ 10 g/dl (6,2 mmol/l)).
English: Only one dose of Abseamed from each syringe should be taken.
Danish: Der må kun udtages én dosis Abseamed fra hver injektionssprøjte.
English: If the haemoglobin is rising by more than 2 g/dL (1.25 mmol/L) per month, or if the sustained haemoglobin exceeds 12 g/dL (7.5 mmol/L) reduce the Abseamed dose by 25%.
Danish: Hvis hæmoglobin stiger over 2 g/dl (1,25 mmol/l) pr. måned, eller hvis hæmoglobin vedvarende overstiger 12 g/dl (7,5 mmol/l), reduceres Abseamed-dosis med 25%.
English: Abseamed is one of a group of products that stimulate the production of red blood cells like the human protein erythropoietin does.
Danish: Abseamed tilhører en gruppe lægemidler, som stimulerer produktionen af røde blodlegemer, ligesom det humane protein erytropoietin gør det. Din læge og sundhedspersonalet vil altid notere præcist det lægemiddel, du får.
English: Abseamed should be administered to patients with anaemia (e.g. haemoglobin concentration ≤ 10 g/dL (6.2 mmol/L)).
Danish: Abseamed skal indgives til patienter med anæmi (f.eks. hæmoglobinkoncentration ≤ 10 g/dl (6,2 mmol/l)).
English: If the haemoglobin concentration is increasing by more than 2 g/dL (1.25 mmol/L) per month, or if the haemoglobin concentration level exceeds 12 g/dL (7.5 mmol/L), reduce the Abseamed dose by about 25 to 50%.
Danish: Hvis hæmoglobinkoncentrationen stiger med mere end 2 g/dl (1,25 mmol/l) pr. måned, eller hvis hæmoglobinkoncentrationen overstiger 12 g/dl (7,5 mmol/l), skal Abseamed-dosis reduceres med ca.
English: If the haemoglobin exceeds 13 g/dL (8.1 mmol/L), discontinue therapy until it falls below 12 g/dL (7.5 mmol/L) and then reinstitute Abseamed therapy at a dose 25% below the previous dose.
Danish: Hvis hæmoglobin overstiger 13 g/dl (8,1 mmol/l), skal behandlingen seponeres, indtil niveauet falder til under 12 g/dl (7,5 mmol/l), hvorefter behandling med Abseamed genstartes ved en dosis, der er 25% under den tidligere dosis.
English: If the haemoglobin concentration level exceeds 13 g/dL (8.1 mmol/L), discontinue therapy until it falls below 12 g/dL (7.5 mmol/L) and then reinitiate Abseamed therapy at a dose 25% below the previous dose.
Danish: Hvis hæmoglobinkoncentrationen overstiger 13 g/dl (8,1 mmol/l), skal behandlingen afbrydes, til det falder til under 12 g/dl (7,5 mmol/l), og derefter genoptages med en Abseamed-dosis, som ligger 25% under den tidligere dosis.
English: Instructions on how to inject yourself with Abseamed can be found at the end of this leaflet.
Danish: Du kan finde en vejledning om, hvordan du giver dig selv en injektion af Abseamed sidst i denne indlægsseddel.
English: INFORMATION IN BRAILLE Abseamed 8,000 IU/0.8 mL
Danish: INFORMATION I BRAILLESKRIFT Abseamed 8.000 IE/0,8 ml
English: INFORMATION IN BRAILLE Abseamed 30,000 IU/0.75 mL
Danish: INFORMATION I BRAILLESKRIFT Abseamed 30.000 IE/0,75 ml
English: INFORMATION IN BRAILLE Abseamed 9,000 IU/0.9 mL
Danish: INFORMATION I BRAILLESKRIFT Abseamed 9.000 IE/0,9 ml
English: What is in this leaflet What Abseamed is and what it is used for What you need to know before you use Abseamed How to use Abseamed Possible side effects How to store Abseamed Contents of the pack and other information What Abseamed is and what it is used for Abseamed contains the active substance epoetin alfa, a protein that stimulates the bone marrow to produce more red blood cells which carry haemoglobin (a substance that transports oxygen).
Danish: Abseamed indeholder det aktive stof epoetin alfa, et protein som stimulerer knoglemarven til at danne flere røde blodlegemer, der bærer hæmoglobin (et stof, der transporterer oxygen).
English: Do not administer Abseamed by intravenous infusion or in conjunction with other medicinal product solutions (please refer to section 6.6 for further information).
Danish: Abseamed må ikke administreres som intravenøs infusion eller sammen med andre injektionsvæsker, der indeholder et lægemiddel (se pkt.
English: In paediatric patients with chronic renal failure where intravenous access is routinely available (haemodialysis patients) administration of Abseamed by the intravenous route is preferable.
Danish: Hos pædiatriske patienter med kronisk nyreinsufficiens, hvor intravenøs adgang normalt er tilgængelig (hæmodialysepatienter), er intravenøs administration af Abseamed at foretrække.
English: In patients with chronic renal failure where intravenous access is routinely available (haemodialysis patients) administration of Abseamed by the intravenous route is preferable.
Danish: Hos patienter med kronisk nyreinsufficiens, hvor intravenøs adgang normalt er tilgængelig (hæmodialysepatienter), er intravenøs administration af Abseamed at foretrække.
English: INFORMATION IN BRAILLE Abseamed 7,000 IU/0.7 mL
Danish: INFORMATION I BRAILLESKRIFT Abseamed 7.000 IE/0,7 ml
English: Where intravenous access is not readily available Abseamed may be administered subcutaneously.
Danish: Voksne peritonealdialysepatienter Hvis intravenøs adgang ikke er umiddelbart tilgængelig, kan Abseamed administreres subkutant.
English: If you use more Abseamed than you should
Danish: Hvis du har taget for meget Abseamed
English: INFORMATION IN BRAILLE Abseamed 6,000 IU/0.6 mL
Danish: INFORMATION I BRAILLESKRIFT Abseamed 6.000 IE/0,6 ml
English: INFORMATION IN BRAILLE Abseamed 40,000 IU/1 mL
Danish: INFORMATION I BRAILLESKRIFT Abseamed 40.000 IE/1 ml
English: INFORMATION IN BRAILLE Abseamed 4,000 IU/0.4 mL
Danish: INFORMATION I BRAILLESKRIFT Abseamed 4.000 IE/0,4 ml
English: Abseamed 8,000 IU/0.8 mL solution for injection in a pre-filled syringe Each syringe contains 0.8 mL of solution for injection.
Danish: Abseamed 8.000 IE/0,8 ml injektionsvæske, opløsning i fyldt injektionssprøjte Hver fyldt injektionssprøjte indeholder 0,8 ml injektionsvæske.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 2,000 IU/1 mL injection
Danish: LÆGEMIDLETS NAVN, STYRKE OG/ELLER ADMINISTRATIONSVEJ(E) Abseamed 2.000 IE/1 ml injektionsvæske
English: Abseamed 2,000 IU/1 mL solution for injection in a pre-filled syringe Each mL of solution contains 2,000 IU of epoetin alfa* corresponding to 16.8 micrograms per mL
Danish: Abseamed 2.000 IE/1 ml injektionsvæske, opløsning i fyldt injektionssprøjte Hver ml opløsning indeholder 2.000 IE epoetin alfa*, svarende til 16,8 mikrogram per ml.
English: Abseamed 9,000 IU/0.9 mL solution for injection in a pre-filled syringe Each syringe contains 0.9 mL of solution for injection.
Danish: Abseamed 9.000 IE/0,9 ml injektionsvæske, opløsning i fyldt injektionssprøjte Hver fyldt injektionssprøjte indeholder 0,9 ml injektionsvæske.
English: INFORMATION IN BRAILLE Abseamed 20,000 IU/0.5 mL
Danish: INFORMATION I BRAILLESKRIFT Abseamed 20.000 IE/0,5 ml
English: INFORMATION IN BRAILLE Abseamed 1,000 IU/0.5 mL
Danish: INFORMATION I BRAILLESKRIFT Abseamed 1.000 IE/0,5 ml
English: Abseamed 8,000 IU/0.8 mL solution for injection in a pre-filled syringe EU/1/07/412/013
Danish: Abseamed 8.000 IE/0,8 ml injektionsvæske, opløsning i fyldt injektionssprøjte EU/1/07/412/013
English: Abseamed 9,000 IU/0.9 mL solution for injection in a pre-filled syringe
Danish: Abseamed 9.000 IE/0,9 ml injektionsvæske, opløsning i fyldt injektionssprøjte
English: Abseamed 30,000 IU/0.75 mL solution for injection in a pre-filled syringe Each syringe contains 0.75 mL of solution for injection.
Danish: Abseamed 30.000 IE/0,75 ml injektionsvæske, opløsning i fyldt injektionssprøjte Hver fyldt injektionssprøjte indeholder 0,75 ml injektionsvæske.
English: Abseamed 7,000 IU/0.7 mL solution for injection in a pre-filled syringe Each syringe contains 0.7 mL of solution for injection.
Danish: Abseamed 7.000 IE/0,7 ml injektionsvæske, opløsning i fyldt injektionssprøjte Hver fyldt injektionssprøjte indeholder 0,7 ml injektionsvæske.
English: INFORMATION IN BRAILLE Abseamed 3,000 IU/0.3 mL
Danish: INFORMATION I BRAILLESKRIFT Abseamed 3.000 IE/0,3 ml
English: Abseamed 8,000 IU/0.8 mL solution for injection in a pre-filled syringe
Danish: Abseamed 8.000 IE/0,8 ml injektionsvæske, opløsning i fyldt injektionssprøjte
English: INFORMATION IN BRAILLE Abseamed 5,000 IU/0.5 mL
Danish: INFORMATION I BRAILLESKRIFT Abseamed 5.000 IE/0,5 ml
English: INFORMATION IN BRAILLE Abseamed 2,000 IU/1 mL
Danish: INFORMATION I BRAILLESKRIFT Abseamed 2.000 IE/1 ml
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 9,000 IU/0.9 mL injection
Danish: LÆGEMIDLETS NAVN, STYRKE OG/ELLER ADMINISTRATIONSVEJ(E) Abseamed 9.000 IE/0,9 ml injektionsvæske Epoetin alfa i.v./s.c.
English: Abseamed 40,000 IU/1 mL solution for injection in a pre-filled syringe Each mL of solution contains 40,000 IU of epoetin alfa* corresponding to 336.0 micrograms per mL
Danish: Abseamed 40.000 IE/1 ml injektionsvæske, opløsning i fyldt injektionssprøjte Hver ml opløsning indeholder 40.000 IE epoetin alfa*, svarende til 336,0 mikrogram per ml.
English: Abseamed 30,000 IU/0.75 mL solution for injection in a pre-filled syringe EU/1/07/412/023
Danish: Abseamed 30.000 IE/0,75 ml injektionsvæske, opløsning i fyldt injektionssprøjte EU/1/07/412/023
English: Abseamed 20,000 IU/0.5 mL solution for injection in a pre-filled syringe Each mL of solution contains 40,000 IU of epoetin alfa* corresponding to 336.0 micrograms per mL
Danish: Abseamed 20.000 IE/0,5 ml injektionsvæske, opløsning i fyldt injektionssprøjte Hver ml opløsning indeholder 40.000 IE epoetin alfa*, svarende til 336,0 mikrogram per ml.